Skip to contentLAPORTE KATHLEEN — TRANSGENOMIC INC insider: 201 transactions · InsiderLensLAPORTE KATHLEEN
- 10% owner at WORLD HEART CORP · on record since Aug 8, 2008
- Director at VNUS MEDICAL TECHNOLOGIES INC · on record since May 30, 2006
- Director at ISTA PHARMACEUTICALS INC · on record since Jun 26, 2006
- 10% owner at ISTA PHARMACEUTICALS INC · on record since Jun 26, 2006
- Director at ADEZA BIOMEDICAL CORP · on record since Jun 8, 2006
- Director at AFFYMAX INC · on record since Dec 18, 2006
- Director at eHealth, Inc. · on record since Oct 12, 2006
- Director at NOVACEA INC · on record since Feb 3, 2009
- Board of Director at ISTA PHARMACEUTICALS INC · on record since Sep 16, 2003
- Director at BOLT TECHNOLOGY CORP · on record since Jun 11, 2026
- Director at Q32 Bio Inc. · on record since Jun 16, 2026
- 10% owner at VNUS MEDICAL TECHNOLOGIES INC · on record since Oct 20, 2004
- 10% owner at ADEZA BIOMEDICAL CORP · on record since Dec 9, 2004
- Director at TRANSGENOMIC INC · on record since Aug 13, 2018
- Director at CERO THERAPEUTICS HOLDINGS, INC. · on record since Oct 12, 2021
- Director at 89bio, Inc. · on record since Nov 3, 2021
Insider trading activity of LAPORTE KATHLEEN
- Transactions on record
- 201
- since Sep 16, 2003
- Open-market buys
- 4
- $24K
- Open-market sells
- 16
- $18.9M
- Companies traded
- 10
- last filing Jun 16, 2026
Figures computed from official regulatory filings — methodology.
Companies where LAPORTE KATHLEEN has traded
- Q32 Bio Inc.10 tx · $64K · Jun 16, 2026
- BOLT TECHNOLOGY CORP22 tx · $24K · Jun 11, 2026
- TRANSGENOMIC INC40 tx · $225.8K · Jan 20, 2026
- CERO THERAPEUTICS HOLDINGS, INC.12 tx · $150K · Jan 9, 2026
- 89bio, Inc.13 tx · $268K · Oct 30, 2025
- AFFYMAX INC23 tx · $16.4M · Dec 18, 2012
- NOVACEA INC5 tx · Feb 2, 2012
- ISTA PHARMACEUTICALS INC24 tx · $20.3T · Apr 15, 2011
- VNUS MEDICAL TECHNOLOGIES INC39 tx · May 27, 2008
- ADEZA BIOMEDICAL CORP
Track record of LAPORTE KATHLEEN
Statistical track record
Free- Open-market buys
- 6
- Last buy
- Feb 9, 2021
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of LAPORTE KATHLEEN
Co-insiders of LAPORTE KATHLEEN
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
13 tx · Jun 8, 2006
Fisher DouglasCERO THERAPEUTICS HOLDINGS, INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 16, 2026 | AwardD | 9,810 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | AwardD | 5,000 | 0.00 USD | $0 | SEC |
| Jan 30, 2026 | AwardD | 23,272 | 2.75 USD | $64K | SEC |
| Jan 20, 2026 | Award | 520 | 24.00 USD | $12.5K | SEC |
| Jan 9, 2026 | AwardD | 690,900 | 0.00 USD | $0 | SEC |
| Jan 6, 2026 | AwardD | 1,500 | 0.00 USD | $0 | SEC |
| Dec 16, 2025 | OtherD | -1,250 | — | — | SEC |
| Dec 16, 2025 | OtherD | -1,250 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,392 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,250 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,250 | — | — | SEC |
| Dec 16, 2025 | OtherD | -1,250 | — | — | SEC |
| Dec 16, 2025 | OtherD | -1,100 | — | — | SEC |
| Dec 16, 2025 | OtherD | -1,250 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,100 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,250 | — | — | SEC |
| Dec 16, 2025 | OtherD | -1,392 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,250 | — | — | SEC |
| Dec 16, 2025 | AwardD | 1,100 | — | — | SEC |
| Dec 16, 2025 | OtherD | -1,100 | — | — | SEC |
| Oct 30, 2025 | OtherD | -56,400 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -25,000 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -27,400 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -12,500 | 0.00 USD | $0 | SEC |
| Oct 30, 2025 | OtherD | -45,150 | 0.00 USD | $0 | SEC |